BioSensics
BioSensics, based in Cambridge, US, is a global provider of wearable sensor tech for medical use and research.
Founded
2007BioSensics, based in Cambridge, US, is a global provider of wearable sensor tech for medical use and research.
Founded in Cambridge, US, BioSensics is a leading provider of wearable sensor technologies designed for clinical research and medical applications. The company's mission is to enhance healthcare outcomes through innovative digital health solutions. Their product lineup includes wearable devices like BalanSens, LEGSys, and PAMSys, which are used to monitor balance, gait, and physical activity. Additionally, BioSensics offers digital health solutions such as BioDigit Speech and BioDigit Video, aimed at facilitating clinical trials and remote patient monitoring.
BioSensics has garnered attention for its contributions to research in neurodegenerative and neuromuscular disorders, including Parkinson’s disease and amyotrophic lateral sclerosis. The company collaborates with prominent researchers and institutions to advance the understanding and treatment of these conditions. Notable achievements include the development of comprehensive biomarker databases and successful integration of their technologies in clinical trials. BioSensics' impact is evident in its ability to provide critical data that supports medical advancements and improves patient care globally.
Companies similar to BioSensics include BioSensys, MediSens, BioSens8 and LifeSignals.
BioSensics was founded in 2007.
BioSensics' headquarters is located in Newton, MA, US.
BioSensics' most recent funding round was for $2.5M (USD) in September 2017.
As of Sep 20, 2017, BioSensics has disclosed funding of $2.5M (USD). Undisclosed round amounts are excluded.
BioSensics has 25 employees as of Feb 4, 2024.
lifesignals.com
